Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.

MLA

Hao, Yi-ning, et al. “Cerebral Inoculation of Human A53T α-Synuclein Reduces Spatial Memory Decline and Amyloid-β Aggregation in APP/PS1 Transgenic Mice of Alzheimer’s Disease.” Brain Research Bulletin, vol. 143, Oct. 2018, pp. 116–22. EBSCOhost, https://doi.org/10.1016/j.brainresbull.2018.10.003.

APA

Hao, Y., Lu, Q., Zhai, Y., Wang, H., Wu, M., Hu, M., Yang, B., Wang, Z., Wu, Z., & Qi, J. (2018). Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer’s disease. Brain Research Bulletin, 143, 116–122. https://doi.org/10.1016/j.brainresbull.2018.10.003

Chicago

Hao, Yi-ning, Qi-xuan Lu, Yu-hao Zhai, Hao-yue Wang, Mei-na Wu, Meng-ming Hu, Biao Yang, Zhao-jun Wang, Ze-wen Wu, and Jin-shun Qi. 2018. “Cerebral Inoculation of Human A53T α-Synuclein Reduces Spatial Memory Decline and Amyloid-β Aggregation in APP/PS1 Transgenic Mice of Alzheimer’s Disease.” Brain Research Bulletin 143 (October): 116–22. doi:10.1016/j.brainresbull.2018.10.003.